Sensorineural hearing loss: a reversible effect of vigabatrin.
Papadeas
E
E
University Department of Otorhinolaryngology, University Hospital of Patras, Greece.
Polychronopoulos
P
P
Papathanasopoulos
P
P
Frimas
C
C
Pharmakakis
N
N
Paschalis
C
C
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D001299:Audiometry; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis*; D006801:Humans; D008297:Male; D020127:Recovery of Function; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000150:complications / Q000175:diagnosis
D000927:Anticonvulsants; D020888:Vigabatrin